Groundbreaking Insights Into SIRT1 / NRF2 ‐Mediated Ferroptosis Inhibition by Resveratrol in Parkinson's Disease Models

Documenti analoghi

• CircMAN1A2 Levels Determine GBM Susceptibility to TMZ in a Pathway Involving TEP1‐ and KEAP1‐Mediated NRF2 Degradation Leading to Ferroptosis
  di: Xinqiao Li, et al.
  Pubblicazione: (2025)
• Insulin‐Like Growth Factor Binding Protein 2 Drives Neurodegeneration in Parkinson's Disease: Insights From In Vivo and In Vitro Studies
  di: Jing An, et al.
  Pubblicazione: (2024)
• Dihydroartemisinin Alleviates Neuronal Damage and Seizures in Epileptic Mice by Inhibiting Ferroptosis via the SIRT1 / FOXO1 / SLC7A11 / GPX4 Pathway
  di: Zhipeng You, et al.
  Pubblicazione: (2026)
• Novel Insights Into the Causal Effects and Shared Genetics Between Body Fat and Parkinson Disease
  di: Qian Zhao, et al.
  Pubblicazione: (2024)
• Novel Insights Into the Association Between Parkinson's Disease and Constipation: Role of SHMT2 as a Promising Biomarker
  di: Jiehua Su, et al.
  Pubblicazione: (2026)